Cargando…
Development and Validation of Quantitative Real-Time PCR for the Detection of Residual CHO Host Cell DNA and Optimization of Sample Pretreatment Method in Biopharmaceutical Products
BACKGROUND: The presence of residual DNA carried by biological products in the body may lead to an increased oncogenicity, infectivity, and immunomodulatory risk. Therefore, current agencies including WHO, EU, and the FDA limited the accepted amounts of residual DNA (less than 10 ng or 100 pg/dose)....
Autores principales: | Zheng, Weifeng, Jiang, Lin, Lei, Qing, Yang, Jun, Gao, Xuefeng, Wang, Wanru, Zhang, Yanli, Kong, Tao, Chen, Qiaoli, Li, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717637/ https://www.ncbi.nlm.nih.gov/pubmed/31496923 http://dx.doi.org/10.1186/s12575-019-0105-1 |
Ejemplares similares
-
Development of real time PCR for detection and quantitation of Dengue Viruses
por: Gurukumar, KR, et al.
Publicado: (2009) -
Detection and quantification of Flavobacterium psychrophilum in water and fish tissue samples by quantitative real time PCR
por: Strepparava, Nicole, et al.
Publicado: (2014) -
Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR
por: Seaman, William T, et al.
Publicado: (2010) -
Identification of reliable reference genes for quantitative real-time PCR normalization in pitaya
por: Chen, Canbin, et al.
Publicado: (2019) -
Comparative evaluation of a laboratory-developed real-time PCR assay and RealStar® Adenovirus PCR Kit for quantitative detection of human adenovirus
por: Wong, Samson S. Y., et al.
Publicado: (2018)